Literature DB >> 19615407

Emerging roles of peroxisome proliferator-activated receptor-beta/delta in inflammation.

David Bishop-Bailey1, Jonas Bystrom.   

Abstract

Peroxisome proliferator-activated receptor (PPAR)-beta/delta is a member of the PPAR nuclear hormone receptor family. The PPARs are a family of 3 ligand-activated transcription factors: PPARalpha (NR1C1), PPARbeta/delta (NR1C2), and PPARgamma (NR1C3). All the PPARs play important roles in the regulation of metabolic pathways, including those of lipid of biosynthesis and glucose metabolism, as well as in a variety of cell differentiation, proliferation, and apoptosis pathways. Recently, there has been a great deal of interest in the involvement of PPARs in the inflammatory processes. In particular, PPARalpha and PPARgamma inhibit the activation of inflammatory gene expression and can negatively interfere with pro-inflammatory transcription factor signalling pathways in vascular and inflammatory cells. In contrast, the roles of PPARbeta/delta regulating inflammation and immunity are only just emerging. This review will focus on these emerging roles of PPARbeta/delta in regulating inflammatory processes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19615407     DOI: 10.1016/j.pharmthera.2009.06.011

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  49 in total

Review 1.  Mechanisms of inflammatory responses in obese adipose tissue.

Authors:  Shengyi Sun; Yewei Ji; Sander Kersten; Ling Qi
Journal:  Annu Rev Nutr       Date:  2012-03-09       Impact factor: 11.848

2.  Poly-glutamine expanded huntingtin dramatically alters the genome wide binding of HSF1.

Authors:  Laura Riva; Martina Koeva; Ferah Yildirim; Leila Pirhaji; Deepika Dinesh; Tali Mazor; Martin L Duennwald; Ernest Fraenkel
Journal:  J Huntingtons Dis       Date:  2012

Review 3.  Emerging roles of the corepressors NCoR1 and SMRT in homeostasis.

Authors:  Adrienne Mottis; Laurent Mouchiroud; Johan Auwerx
Journal:  Genes Dev       Date:  2013-04-15       Impact factor: 11.361

4.  PPARδ prevents radiation-induced proinflammatory responses in microglia via transrepression of NF-κB and inhibition of the PKCα/MEK1/2/ERK1/2/AP-1 pathway.

Authors:  Caroline I Schnegg; Mitra Kooshki; Fang-Chi Hsu; Guangchao Sui; Mike E Robbins
Journal:  Free Radic Biol Med       Date:  2012-03-03       Impact factor: 7.376

5.  Modulation of VEGF-induced retinal vascular permeability by peroxisome proliferator-activated receptor-β/δ.

Authors:  Sandra Suarez; Gary W McCollum; Colin A Bretz; Rong Yang; Megan E Capozzi; John S Penn
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-11-18       Impact factor: 4.799

6.  Kukoamine A Prevents Radiation-Induced Neuroinflammation and Preserves Hippocampal Neurogenesis in Rats by Inhibiting Activation of NF-κB and AP-1.

Authors:  Yaqiong Zhang; Lingyue Gao; Zhihua Cheng; Jiayi Cai; Yixuan Niu; Weihong Meng; Qingchun Zhao
Journal:  Neurotox Res       Date:  2016-11-04       Impact factor: 3.911

Review 7.  Peroxisome proliferator activating receptor (PPAR) in cerebral malaria (CM): a novel target for an additional therapy.

Authors:  S Balachandar; A Katyal
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-12-09       Impact factor: 3.267

8.  The anti-inflammatory effects of interleukin-4 are not mediated by suppressor of cytokine signalling-1 (SOCS1).

Authors:  Eleanor A Woodward; Cecilia M Prêle; Sandra E Nicholson; Tatiana B Kolesnik; Prue H Hart
Journal:  Immunology       Date:  2010-04-06       Impact factor: 7.397

9.  Peroxisome Proliferator-Activated Receptors Protect against Apoptosis via 14-3-3.

Authors:  Kenneth K Wu
Journal:  PPAR Res       Date:  2010-08-24       Impact factor: 4.964

10.  CLA reduces inflammatory mediators from A427 human lung cancer cells and A427 conditioned medium promotes differentiation of C2C12 murine muscle cells.

Authors:  Manuela Oraldi; Marina Maggiora; Elena Paiuzzi; Rosa A Canuto; Giuliana Muzio
Journal:  Lipids       Date:  2012-11-07       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.